Collectively, these findings suggest that FILIP1L downregulation leads to neoplastic changes associated with adenocarcinoma differentiation, confirming the tumor suppressor function of FILIP1L in the lungs. This evidence concerns the gene FILIP1L and adenocarcinoma.